Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPGDS | O60760 | 1/20 | 0.56 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.55 |
| ▸ | BAZ2B | Q9UIF8 | 1/20 | 0.54 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.54 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.54 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.54 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.53 |
| ▸ | HPGD | P15428 | 1/20 | 0.53 |
| ▸ | MAPT | P10636 | 1/20 | 0.53 |
| ▸ | PDE5A | O76074 | 1/20 | 0.49 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.48 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.47 |
| ▸ | LDHA | P00338 | 1/20 | 0.47 |
| ▸ | TOP2A | P11388 | 1/20 | 0.46 |
| ▸ | GABRA5 | P31644 | 1/20 | 0.45 |
| ▸ | DRD2 | P14416 | 1/20 | 0.44 |
| ▸ | DRD4 | P21917 | 1/20 | 0.44 |
| ▸ | DRD3 | P35462 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16495427 | 0.89 | CYP1A2 (0.52) | HPGDSHDAC1CYP3A4CYP2C19CYP1A2 | |
| SCHEMBL16495755 | 0.87 | NPC1 (0.54) | HPGDSHDAC1CYP3A4CYP2C19CYP1A2 | |
| SCHEMBL16495700 | 0.87 | TRPV1 (0.51) | HPGDSHDAC1CYP3A4CYP2C19CYP1A2 | |
| SCHEMBL16495680 | 0.84 | HPGDS (0.65) | HPGDSHDAC1BAZ2BSMN1; SMN2KDM4E | |
| SCHEMBL16495731 | 0.84 | NPC1 (0.50) | HPGDSHDAC1CYP3A4CYP2C19CYP1A2 | |
| SCHEMBL16496356 | 0.83 | HPGDS (0.64) | HPGDSHDAC1BAZ2BSMN1; SMN2KDM4E | |
| SCHEMBL5009820 | 0.81 | MAPT (0.62) | HDAC1CYP3A4CYP2C19CYP1A2SMN1; SMN2 | |
| SCHEMBL16495930 | 0.81 | HPGDS (0.53) | HPGDSCYP3A4CYP2C19CYP1A2SMN1; SMN2 | |
| SCHEMBL20267109 | 0.80 | HPGDS (0.70) | HPGDSHDAC1BAZ2BSMN1; SMN2TRPV1 | |
| SCHEMBL16495619 | 0.80 | L3MBTL1 (0.56) | HPGDSBAZ2BALDH1A1KDM4EHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110306597-A1 | Nicotinamide Derivatives | CRAWFORTH JAMES MICHAEL (GB) | 2011-12-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110306597-A1 | Nicotinamide Derivatives | NNT, NAMPT, NQO1 | HPGDS 1073/4885HDAC1 121/4885BAZ2B 1779/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.